Clinical trial
Ablation as First Line Treatment in Paroxysmal Atrial Fibrillation
NCT01466842 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ablation as First Line Treatment in Paroxysmal Atrial Fibrillation
- Lead sponsor
- Maastricht University Medical Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2012
- Completion date
- January 31, 2016
- Enrollment
- 160 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
paroxysmal atrial fibrillation